Malaria research and its influence on anti-malarial drug policy in Malawi: a case study

@inproceedings{Mwendera2016MalariaRA,
  title={Malaria research and its influence on anti-malarial drug policy in Malawi: a case study},
  author={Chikondi A. Mwendera and Christiaan de Jager and Herbert Longwe and Kamija Samuel Phiri and Charles Hongoro and Clifford Maina Mutero},
  booktitle={Health research policy and systems},
  year={2016}
}
BACKGROUND In 1993, Malawi changed its first-line anti-malarial treatment for uncomplicated malaria from chloroquine to sulfadoxine-pyrimethamine (SP), and in 2007, it changed from SP to lumefantrine-artemether. The change in 1993 raised concerns about whether it had occurred timely and whether it had potentially led to early development of Plasmodium… CONTINUE READING